Evidence map›Paper›PMID 36185200›Full record

ArticleFrontiers in oncology2022

Ubiquitin-related lncRNAs: The new tool for prognosis prediction in prostate cancer.

Xiang Liu, Wangli Mei, Liang Jin, Xianchao Sun, Zhen Zhou, Shiyong Xin, Liqun Huang, Guosheng Yang, Jinyou Wang, Lin Ye

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiang LiuDepartment of Urology, Putuo People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Wangli MeiDepartment of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Liang JinDepartment of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Xianchao SunDepartment of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Zhen ZhouDepartment of Urology, Putuo People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Shiyong XinDepartment of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Liqun HuangDepartment of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Guosheng YangDepartment of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Jinyou WangDepartment of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Lin YeDepartment of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To establish a ubiquitin-related long noncoding ribonucleic acids (lncRNAs) prognosis prediction model for prostate cancer (Pca). Methods: Data were acquired through The Cancer Genome Atlas (TCGA) database. Ubiquitin-related differentially expressed genes (DEGs) and lncRNAs in Pca were filtered out. UBE2S was selected as the representative gene and validated Results: A total of 254 ubiquitin-related genes were screened. UBE2S was shown to promote the proliferation of Pca cells Conclusion: The ubiquitin-related lncRNAs can effectively predict the prognosis of Pca and may provide new treatment options for Pca.

Indexed as

lncRNAprognosisprogression-free survivalprostate cancerubiquitin

Identifiers

PMID36185200
PMCPMC9524195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.